Our Technology

An unprecedented, cutting-edge detection technology using gold nanoparticles and current measurement

GLEIA

GLEIA, which forms the core of our technology, was developed by Dr. Eiichi Tamiya, a specially appointed professor in AIST-Osaka University Advanced Photonics and Biosensing Open Innovation Laboratory (currently).
It is an excellent technology based on a sandwich-type immunoassay method that can achieve high detection sensitivity with a simple system configuration by electrochemically quantifying the amount of gold atoms contained in gold nanoparticles as a label for antibodies.
It has enabled us to reduce the size of the testing kit and increase the accuracy, which had been difficult in conventional methods.

*GLEIA:Gold Linked Electrochemical Immuno Assay

GLEIA

How GLEIA works

How GLEIA works

[Video explaining the principle]

Main patent

  • Title of
    invention

    Method for determination of test substance

  • Patent
    number

    JP5187759

  • Title of
    invention

    Electrochemical lateral flow immunological test method, sensor for same, and method for manufacturing same

  • Patent
    number

    JP6714256